Avricore Health
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.65-9.12-1.18-1.79-0.66-0.40-4.30-8.30-36.07-20.67-35.40-0.40
Price/Sales ratio
49.783.51K3.0411.6115.7526.03173.92118.1016.864.1633.5115.75
Price/Book Value ratio
6.255.991.612.504.02-1.84-8.046.6015.187.2115.814.02
Price/Cash Flow ratio
-7.69-13.53-1.49-3.53-2.06-1.25-4.69-11.75-68.0921.95-40.27-1.25
Price/Free Cash Flow ratio
-7.26-13.25-1.49-3.52-2.00-1.25-4.69-10.55-18.22-37.51-18.82-1.25
Price/Earnings Growth ratio
0.02-0.120.22-0.320.040.000.080.570.641.2416.68K0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
14.76%56.39%29.86%45.90%16.80%43.93%52.92%24.85%25.83%34.52%35.97%16.80%
Operating Profit Margin
-929.25%-30254.27%-230.20%-369.49%-1272.64%-4850.00%-2601.13%-1420.92%-45.79%-16.73%-103.80%-1272.64%
Pretax Profit Margin
-880.44%-38520.00%-257.86%-508.95%-1826.84%-5806.82%-3554.24%-1390.89%-46.27%-20.12%-94.67%-1826.84%
Net Profit Margin
-880.44%-38520.00%-257.86%-648.36%-2380.99%-6402.56%-4035.47%-1422.19%-46.74%-20.12%-94.67%-2380.99%
Effective Tax Rate
5.44%-42.92%-21.58%-27.39%-30.33%-10.25%-13.53%-2.25%-1.02%N/AN/A-30.33%
Return on Assets
-89.46%-62.15%-114.88%-120.21%-449.22%-1013.84%-302.87%-76.55%-32.17%-27.62%-36.76%-449.22%
Return On Equity
-110.68%-65.62%-136.28%-139.55%-608.56%453.93%186.67%-79.50%-42.08%-34.90%-39.80%-608.56%
Return on Capital Employed
-116.82%-51.54%-121.66%-79.53%-325.27%343.86%120.32%-79.42%-41.23%-29.03%-48.98%-325.27%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.55N/A
Quick Ratio
-0.2716.763.323.632.070.300.3825.552.361.423.312.07
Cash ratio
1.8714.551.191.390.260.020.2623.821.020.522.300.26
Days of Sales Outstanding
68.437.23K240.85305.75311.84136.87108.29249.20154.4144.09167.64136.87
Days of Inventory outstanding
1.83K52.20K542.32265.05198.58N/A0.02N/AN/A3.30N/AN/A
Operating Cycle
1.89K59.43K783.18570.81510.42136.87108.31249.20154.4147.3941.33136.87
Days of Payables Outstanding
884.1616.28K51.51201.08438.9712.33K2.97K175.9072.7768.57232.5012.33K
Cash Conversion Cycle
1.01K43.14K731.66369.7271.45-12.20K-2.86K73.2981.63-21.17-64.86-12.20K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A2.270.010.010.010.17N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A-1.400.010.020.010.21N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A3.480.010.010.01N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.19KN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-1.22-30.85-10.9416.51N/AN/A
Company Equity Multiplier
1.231.051.181.161.35-0.44-0.611.031.301.261.211.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-6.47-259.85-2.03-3.28-7.61-20.80-37.03-10.04-0.240.18-0.83-7.61
Free Cash Flow / Operating Cash Flow Ratio
1.051.021.001.001.03111.113.73-0.582.131.03
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-1.22-30.85-10.9416.51N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-1.22-30.85-10.9416.51-17.19N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A